David Mahvi to Interleukin-12
This is a "connection" page, showing publications David Mahvi has written about Interleukin-12.
Connection Strength
1.364
-
Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial. Cancer Gene Ther. 2007 Aug; 14(8):717-23.
Score: 0.282
-
IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model. J Surg Res. 2004 Dec; 122(2):210-7.
Score: 0.237
-
Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study. Hum Gene Ther. 2003 Jul 20; 14(11):1037-48.
Score: 0.215
-
Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol Cancer Ther. 2002 Sep; 1(11):949-57.
Score: 0.203
-
B7.1 expression eliminates tumor resistance to IL-12 gene therapy. Cancer Gene Ther. 2001 Feb; 8(2):118-27.
Score: 0.182
-
Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors. Ann Surg Oncol. 1999 Mar; 6(2):186-94.
Score: 0.159
-
Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer. Hum Gene Ther. 2001 Jan 20; 12(2):149-60.
Score: 0.045
-
Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA. Proc Natl Acad Sci U S A. 1999 Nov 09; 96(23):13351-6.
Score: 0.042